EWA Alicja OGŁODEK

Dr. EWA Alicja OGŁODEK


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
MJMarek J. Just
Marek J. Just
Adam R. SzromekAdam R. Szromek
Adam R. Szromek
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 October 2014 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek Just
Marek Just
DMDanuta Moś
Danuta Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 October 2014 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek J. Just
Marek J. Just
DMDanuta Moś
Danuta Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

1 December 2018 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
MJMarek J. Just
Marek J. Just

1 February 2015 in Pharmacological Reports
Verified
Journal Article
Closed access
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
ASAnna Maria Szota
Anna Maria Szota
MJMarek J. Just
Marek J. Just
DMDanuta M. Moś
Danuta M. Moś
AAAleksander Araszkiewicz
Aleksander Araszkiewicz

14 March 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
EOEWA Alicja OGŁODEK
EWA Alicja OGŁODEK
Background: Both depressive disorders (DD) and post-traumatic stress disorders (PTSD) are caused by immune system dysfunction. Affected individuals show increased proinflammatory cytokine concentration levels. Also, it has been hypothesized that DD and PTSD might be associated with a generalized proinflammatory cytokine signature. The study assessed the concentration of IL-1β, IL-4, IL-8 and IL-10 in depression alone and with PTSD. Methods: The study involved 460 participants. Out of them, 420 subjects comprised a study group and 40 subjects comprised a control group. Each study group consisted of 60 patients with mild depression (MD), moderate depression (MOD), severe depression (SeD), MD and PTSD (MD + PTSD), MOD and PTSD (MOD + PTSD), SeD and PTSD (SeD + PTSD), and with PTSD alone. All patients had serum concentration of IL-1β, IL-4, IL-8 and IL-10 measured with ELISA. Results: DD and PTSD are reflected in IL-1β, IL-4, IL-8 and IL-10 concentration levels. It was reported that mean levels of IL-1β, IL-4, IL-8 increase as depression became more severe. A regular decrease in IL-10 concentration levels was noted with the onset and exacerbation of depressive symptoms. Conclusion: The findings might be useful when considering chronic inflammation as a potential target or biomarker in depression and PTSD treatment.